SCHEMBL474209

SCHEMBL474209

COC(=O)c1cc(OCc2ccccc2)ccc1NC1CCN(C(=O)O)CC1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 1/20 0.45
HSD17B10 Q99714 2/20 0.45
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
KIT P10721 1/20 0.44
PRMT5 O14744 2/20 0.43
MAPT P10636 2/20 0.43
MAOB P27338 2/20 0.42
HPGD P15428 1/20 0.42
YAP1 P46937 3/20 0.42
CCR8 P51685 1/20 0.42
MAOA P21397 1/20 0.41
OXTR P30559 1/20 0.41
FAAH O00519 1/20 0.41
HTR6 P50406 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL99959 0.89 PRMT5 (0.55) CACNA1BKDM4EALDH1A1PRMT5MAPT
SCHEMBL474222 0.84 YAP1 (0.42) HSD17B10KDM4EALDH1A1GAAMAPT
SCHEMBL2609164 0.81 GRIN1 (0.46) KDM4EALDH1A1MAPTMAOBHPGD
SCHEMBL14775718 0.80 YAP1 (0.42) HSD17B10KDM4EALDH1A1GAAMAPT
SCHEMBL23724311 0.79 CACNA1B (0.62) CACNA1BALDH1A1MAPTFAAH
SCHEMBL4895612 0.77 BRD4 (0.57) KDM4EALDH1A1MAPTMAOBHPGD
SCHEMBL12763828 0.75 KDM4E (0.51) HSD17B10KDM4EALDH1A1MAPTHPGD
SCHEMBL2609089 0.74 MAOB (0.50) KDM4EALDH1A1MAPTMAOBHPGD
SCHEMBL14783746 0.74 CACNA1B (0.46) CACNA1BPRMT5MAPTMAOBFAAH
SCHEMBL474324 0.74 CACNA1B (0.41) CACNA1BGAAMAPTYAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2205593-B1 QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF SANOFI SA (FR) 2016-01-13 EP disclosed
EP-2416777-B1 THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES SANOFI SA (FR) 2014-11-12 EP disclosed
EP-2411009-B1 Therapeutic uses of quinazolinedione derivatives SANOFI SA (FR) 2013-03-20 EP disclosed
EP-2416777-A1 THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES SANOFI (FR) 2012-02-15 EP disclosed
EP-2411009-A1 THERAPEUTIC USES OF QUINAZOLINEDIONE DERIVATIVES SANOFI (FR) 2012-02-01 EP disclosed
WO-2010116090-A1 THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES SANOFI-AVENTIS (FR) 2010-10-14 WO disclosed
WO-2010109148-A1 THERAPEUTIC USES OF QUINAZOLINEDIONE DERIVATIVES SANOFI-AVENTIS (FR) 2010-09-30 WO disclosed
EP-2205593-A1 QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF Sanofi-Aventis (FR) 2010-07-14 EP disclosed
WO-2009077680-A1 QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF SANOFI-AVENTIS (FR) 2009-06-25 WO disclosed
WO-2009077680-A1 QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF SANOFI-AVENTIS (FR) 2009-06-25 WO disclosed